CentriMag Circulatory Support System
Abbott · Decision date Apr 17, 2026
What did the FDA approve?
FDA records P170038/S029 as a supplement to PMA P170038, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Apr 17, 2026.
FDA approval order statement
Approval for labeling changes to the CentriMag Motor Instructions for Use (IFU), CentriMag Blood Pump IFU, and CentriMag Circulatory Support System Operation Manual.
- Regulatory pathway
- PMA supplement
- Supplement type
- Real-Time Process
- Clinical specialty
- Cardiovascular
- Decision date
- Apr 17, 2026
- FDA change category
- Labeling Change - Indications/instructions/shelf life/tradename
Regulatory record facts
- Identifier
- P170038/S029
- Regulatory pathway
- PMA supplement
- Applicant
- Abbott
- Product code
- DSQ
- Decision code
- APPR
- Decision date
- Apr 17, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Ventricular (assist) bypass.
For the original device and its historical approval scope, see PMA P170038. Subsequent supplements may change the device or its indications.
FDA decision timeline
P170038 · Original PMA
CentriMag Circulatory Support System
P170038/S026 · Related supplement
CentriMag Circulatory Support System
P170038/S023 · Related supplement
CentriMag Circulatory Support System
P170038/S025 · Related supplement
CentriMag Circulatory Support System
P170038/S029 received
Application receipt date recorded by FDA.
P170038/S027 · Related supplement
CentriMag Circulatory Support System
P170038/S028 · Related supplement
CentriMag Circulatory Support System
P170038/S029 · FDA decision
Real-Time Process
P170038/S030 · Related supplement
CentriMag Circulatory Support System
P170038/S031 · Related supplement
CentriMag Circulatory Support System
P170038/S032 · Related supplement
CentriMag Circulatory Support System
P170038/S033 · Related supplement
CentriMag Circulatory Support System
P170038/S034 · Related supplement
CentriMag Circulatory Support System
Timeline entries are records held by MedtechLedger for P170038. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P170038
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Abbott | PMA approval | Dec 6, 2019 | FDA | |
CentriMag Circulatory Support SystemP170038/S026 | Abbott | PMA supplement | Aug 21, 2025 | FDA |
CentriMag Circulatory Support SystemP170038/S023 | Abbott | PMA supplement | Sep 29, 2025 | FDA |
CentriMag Circulatory Support SystemP170038/S025 | Abbott | PMA supplement | Dec 1, 2025 | FDA |
CentriMag Circulatory Support SystemP170038/S027 | Abbott | PMA supplement | Feb 3, 2026 | FDA |
CentriMag Circulatory Support SystemP170038/S028 | Abbott | PMA supplement | Feb 18, 2026 | FDA |
CentriMag Circulatory Support SystemP170038/S030 | Abbott | PMA supplement | May 4, 2026 | FDA |
CentriMag Circulatory Support SystemP170038/S031 | Abbott | PMA supplement | May 5, 2026 | FDA |
CentriMag Circulatory Support SystemP170038/S032 | Abbott | PMA supplement | Sep 2, 2026 | FDA |
CentriMag Circulatory Support SystemP170038/S033 | Abbott | PMA supplement | Oct 2, 2026 | FDA |
CentriMag Circulatory Support SystemP170038/S034 | Abbott | PMA supplement | Oct 30, 2026 | FDA |
Explore the linked device profile
Other records with product code DSQ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
EXCOR Pediatric Ventricular Assist DeviceP160035/S054 | Berlin Heart, Inc. | PMA supplement | Oct 30, 2026 | FDA |
EXCOR Pediatric VADP160035/S061 | Berlin Heart, Inc. | PMA supplement | Oct 28, 2026 | FDA |
EXCOR Pediatric Ventricular Assist DeviceP160035/S060 | Berlin Heart, Inc. | PMA supplement | Oct 23, 2026 | FDA |
HeartMate 3 Left Ventricular Assist SystemP160054/S136 | ABBOTT MEDICAL | PMA supplement | Oct 19, 2026 | FDA |
EXCOR Pediatric VADP160035/S056 | Berlin Heart, Inc. | PMA supplement | Oct 14, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 6035 Stoneridge Dr., Pleasanton, CA, 94588
Sources and methodology
- Original FDA record: P170038/S029
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records






